Differences in the use of combined oral contraceptives amongst women with and without acne | Zendy

Helen E. Seaman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Differences in the use of combined oral contraceptives amongst women with and without acne

Author(s) -

Helen E. Seaman

Publication year - 2003

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deg090

Subject(s) - acne , polycystic ovary , medicine , cyproterone acetate , hirsutism , ethinylestradiol , gynecology , levonorgestrel , desogestrel , obstetrics , population , family planning , research methodology , dermatology , hormone , obesity , androgen , environmental health , insulin resistance

Cyproterone acetate combined with ethinyl estradiol (CPA/EE) provides a treatment option for women with acne, hirsutism or polycystic ovary syndrome (PCOS). CPA/EE may be prescribed as an oral contraceptive (OC), but is not licensed as such in the UK. The use of CPA/EE steadily increased after its introduction to the UK market in 1987, but there was a marked increase in its share of the OC market after 1995.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research